| | |
C.H. Unnikrishnan 08:41 PM | November 12,2009
In the past half a decade, big pharmaceutical firms haven’t developed any new blockbuster drugs, the lifeblood for them
|
|
C.H. Unnikrishnan 10:39 PM | November 03,2009
The industry will be paid for the performance of the product and not just for the product, Friend says
|
|
Reuters 04:22 PM | November 02,2009
Banks were among the top losers, also pressured by news that CIT Group Inc, a US lender to hundreds of thousands of small and medium-sized businesses, filed for bankruptcy on Sunday
|
|
C.H. Unnikrishnan 02:17 AM | October 27,2009
US and Europe sales, accounting for almost a third of Lupin’s revenue, rose 28% to Rs3.53 billion in the quarter
|
|
Reuters 02:30 PM | October 23,2009
Pfizer has tapped Cadila Healthcare, Emcure, Intas Pharma and Mankind Pharma, but the Indian companies have not responded favourably to the offers, the Economic Times said
|
|
Reuters 07:13 PM | October 20,2009
The world’s biggest drugmaker, which got much bigger last week with completion of a $67.3 billion acquisition of Wyeth, posted a net profit of $2.88 billion, or 43 cents per share in its last pre-merger quarter
|
|
Reuters 09:02 AM | October 08,2009
IMS said higher-than-anticipated demand caught pharmacies off guard, forcing them to rebuild inventories slashed late last year as they girded for the impact of a deep recession
|
|
02:35 PM | September 22,2009
In a filing to the Bombay Stock Exchange, Zandu Pharmaceutical said at the court convened meeting of the company’s equity shareholders on 11 September
|
|
C.R. Sukumar 11:00 PM | September 14,2009
Dr. Reddy’s Laboratories Ltd’s vice chairman and chief executive G.V. Prasad shares the drug maker’s future ambitions
|
|
Mark to Market | Mobis Philipose and Ravi Ananthanarayanan 09:54 PM | September 14,2009
The pharmaceutical company’s calendar 2008 consolidated balance sheet had a debt of Rs1,302 crore against a net worth of Rs415 crore
|
|
PTI 03:02 PM | September 14,2009
Shares of Suven rose by 5% to hit its upper trading limit of Rs31.55 on the Bombay Stock Exchange
|
|
C.H. Unnikrishnan and Radhieka Pandeya 10:45 PM | July 29,2009
The country’s largest drug maker by market capitalization also incurred one-time severance costs from layoffs
|
|
PTI 04:00 PM | July 09,2009
The company clarified that this is a class III recall, which signifies that the use or exposure to the product is not likely to cause adverse effects
|
|
Bloomberg 10:26 PM | July 08,2009
The decline in profit at the 30 companies on the benchmark BSE sensitive index compares with a 9.4% drop in the previous three months
|
|
12:30 AM | July 07,2009
Budget and its impact across sectors like aviation, information technology, auto, banking, FMCG and others
|
|